{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:05:46Z","timestamp":1770336346656,"version":"3.49.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12020-021-02715-z","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T06:33:11Z","timestamp":1618468391000},"page":"16-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The way toward adulthood for females with nonclassic congenital adrenal hyperplasia"],"prefix":"10.1007","volume":"73","author":[{"given":"Georgia","family":"Ntali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sokratis","family":"Charisis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christo F.","family":"Kylafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Vogiatzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Michala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"2715_CR1","first-page":"650","volume":"37","author":"PW Speiser","year":"1985","unstructured":"P.W. Speiser, B. Dupont, P. Rubinstein, A. Piazza, A. Kastelan, M.I. New, High frequency of nonclassical steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 37, 650\u2013667 (1985)","journal-title":"Am. J. Hum. Genet."},{"key":"2715_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ymgme.2006.12.005","volume":"90","author":"RC Wilson","year":"2007","unstructured":"R.C. Wilson, S. Nimkarn, M. Dumic, J. Obeid, M. Azar, H. Najmabadi, F. Saffari, M.I. New, Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol. Genet. Metab. 90, 414\u2013421 (2007). https:\/\/doi.org\/10.1016\/j.ymgme.2006.12.005","journal-title":"Mol. Genet. Metab."},{"key":"2715_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/gim.2017.46","volume":"19","author":"F Hannah-Shmouni","year":"2017","unstructured":"F. Hannah-Shmouni, R. Morissette, N. Sinaii, M. Elman, T.R. Prezant, W. Chen, A. Pulver, D.P. Merke, Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians. Genet. Med. 19, 1276\u20131279 (2017). https:\/\/doi.org\/10.1038\/gim.2017.46","journal-title":"Genet. Med."},{"key":"2715_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/humupd\/dmx014","volume":"23","author":"E Carmina","year":"2017","unstructured":"E. Carmina, D. Dewailly, H.F. Escobar-Morreale, F. Kelestimur, C. Moran, S. Oberfield, S.F. Witchel, R. Azziz, Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum. Reprod. Update 23, 580\u2013599 (2017). https:\/\/doi.org\/10.1093\/humupd\/dmx014","journal-title":"Hum. Reprod. Update"},{"key":"2715_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"S. Baumgartner-Parzer, M. Witsch-Baumgartner, W. Hoeppner, EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur. J. Hum. Genet. 28, 1341\u20131367 (2020). https:\/\/doi.org\/10.1038\/s41431-020-0653-5","journal-title":"Eur. J. Hum. Genet."},{"key":"2715_CR6","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1210\/jc.2006-1645","volume":"91","author":"MI New","year":"2006","unstructured":"M.I. New, Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 91, 4205\u20134214 (2006). https:\/\/doi.org\/10.1210\/jc.2006-1645","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR7","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"M.I. New, M. Abraham, B. Gonzalez, M. Dumic, M. Razzaghy-Azar, D. Chitayat, L. Sun, M. Zaidi, R.C. Wilson, T. Yuen, Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. U. S. A. 110, 2611\u20132616 (2013). https:\/\/doi.org\/10.1073\/pnas.1300057110","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2715_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/eje.0.1430397","volume":"143","author":"N Weintrob","year":"2000","unstructured":"N. Weintrob, C. Brautbar, A. Pertzelan, Z. Josefsberg, Z. Dickerman, A. Kauschansky, P. Lilos, D. Peled, M. Phillip, S. Israel, Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency. Eur. J. Endocrinol. 143, 397\u2013403 (2000). https:\/\/doi.org\/10.1530\/eje.0.1430397","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1530\/EC-18-0281","volume":"8","author":"S Riedl","year":"2019","unstructured":"S. Riedl, F.W. R\u00f6hl, W. Bonfig, J. Br\u00e4mswig, A. Richter-Unruh, S. Fricke-Otto, M. Bettendorf, F. Riepe, G. Kriegsh\u00e4user, E. Sch\u00f6nau, G. Even, B. Hauffa, H.G. D\u00f6rr, R.W. Holl, K. Mohnike, Genotype\/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients. Endocr. Connect 8, 86\u201394 (2019). https:\/\/doi.org\/10.1530\/EC-18-0281","journal-title":"Endocr. Connect"},{"key":"2715_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1210\/jcem.86.1.7131","volume":"86","author":"C Deneux","year":"2001","unstructured":"C. Deneux, V. Tardy, D. Anne, E. Mornet, L. Billaud, D. Charron, Y. Morel, F. Kuttenn, Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 86, 207\u2013213 (2001). https:\/\/doi.org\/10.1210\/jcem.86.1.7131","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR11","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/jc.2008-1582","volume":"94","author":"M Bidet","year":"2009","unstructured":"M. Bidet, C. Bellann\u00e9-Chantelot, M.B. Galand-Portier, V. Tardy, L. Billaud, K. Laborde, C. Coussieu, Y. Morel, C. Vaury, J.L. Golmard, A. Claustre, E. Mornet, Z. Chakhtoura, I. Mowszowicz, A. Bachelot, P. Touraine, F. Kuttenn, Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J. Clin. Endocrinol. Metab. 94, 1570\u20131578 (2009). https:\/\/doi.org\/10.1210\/jc.2008-1582","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0032-1330007","volume":"45","author":"VO Moura-Massari","year":"2013","unstructured":"V.O. Moura-Massari, D.D. Bugano, J.A. Marcondes, L.G. Gomes, B.B. Mendonca, T.A. Bachega, CYP21A2 genotypes do not predict the severity of hyperandrogenic manifestations in the nonclassical form of congenital adrenal hyperplasia. Horm. Metab. Res. 45, 301\u2013307 (2013). https:\/\/doi.org\/10.1055\/s-0032-1330007","journal-title":"Horm. Metab. Res."},{"key":"2715_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21134622","volume":"21","author":"M Sumi\u0144ska","year":"2020","unstructured":"M. Sumi\u0144ska, K. Bogusz-G\u00f3rna, D. Wegner, M. Fichna, Non-classic disorder of adrenal steroidogenesis and clinical dilemmas in 21-hydroxylase deficiency combined with backdoor androgen pathway. Mini-review and case report. Int. J. Mol. Sci. 21, 1\u201316 (2020). https:\/\/doi.org\/10.3390\/ijms21134622","journal-title":"Int. J. Mol. Sci."},{"key":"2715_CR14","doi-asserted-by":"publisher","unstructured":"D. Pignatelli, S.S. Pereira, R. Pasquali, Androgens in congenital adrenal hyperplasia. Front. Horm. Res. 65\u201376 (2019). https:\/\/doi.org\/10.1159\/000494903","DOI":"10.1159\/000494903"},{"key":"2715_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/EJE-20-0129","volume":"183","author":"AF Turcu","year":"2020","unstructured":"A.F. Turcu, D. El-Maouche, L. Zhao, A.T. Nanba, A. Gaynor, P. Veeraraghavan, R.J. Auchus, D.P. Merke, Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation. Eur. J. Endocrinol. 183, 63\u201371 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0129","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.mce.2016.08.014","volume":"441","author":"E Pretorius","year":"2017","unstructured":"E. Pretorius, W. Arlt, K.H. Storbeck, A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids. Mol. Cell. Endocrinol. 441, 76\u201385 (2017). https:\/\/doi.org\/10.1016\/j.mce.2016.08.014","journal-title":"Mol. Cell. Endocrinol."},{"key":"2715_CR17","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1210\/jc.2018-02605","volume":"104","author":"B Neeman","year":"2019","unstructured":"B. Neeman, R. Bello, L. Lazar, M. Phillip, L. De Vries, Central precocious puberty as a presenting sign of nonclassical congenital adrenal hyperplasia: clinical characteristics. J. Clin. Endocrinol. Metab. 104, 2695\u20132700 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02605","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR18","doi-asserted-by":"publisher","unstructured":"C. Binay, E. Simsek, O. Cilingir, Z. Yuksel, O. Kutlay, S. Artan, Prevalence of nonclassic congenital adrenal hyperplasia in turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea. Int. J. Endocrinol. 2014 (2014). https:\/\/doi.org\/10.1155\/2014\/768506","DOI":"10.1155\/2014\/768506"},{"key":"2715_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/cen.12543","volume":"82","author":"S Livadas","year":"2015","unstructured":"S. Livadas, M. Dracopoulou, A. Dastamani, A. Sertedaki, M. Maniati-Christidi, A.M. Magiakou, C. Kanaka-Gantenbein, G.P. Chrousos, C. Dacou-Voutetakis, The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene. Clin. Endocrinol. 82, 543\u2013549 (2015). https:\/\/doi.org\/10.1111\/cen.12543","journal-title":"Clin. Endocrinol."},{"key":"2715_CR20","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1067\/mob.2000.108020","volume":"183","author":"C Moran","year":"2000","unstructured":"C. Moran, R. Azziz, E. Carmina, D. Dewailly, F. Fruzzetti, L. Iba\u00f1ez, E.S. Knochenhauer, J.A.M. Marcondes, B.B. Mendonca, D. Pignatelli, M. Pugeat, V. Rohmer, P.W. Speiser, S.F. Witchel, 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am. J. Obstet. Gynecol. 183, 1468\u20131474 (2000). https:\/\/doi.org\/10.1067\/mob.2000.108020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2715_CR21","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"P.W. Speiser, W. Arlt, R.J. Auchus, L.S. Baskin, G.S. Conway, D.P. Merke, H.F.L. Meyer-Bahlburg, W.L. Miller, M. Hassan Murad, S.E. Oberfield, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society* clinical practice guideline. J. Clin. Endocrinol. Metab. 103, 4043\u20134088 (2018). https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1152\/physrev.00033.2015","volume":"97","author":"M Almeida","year":"2017","unstructured":"M. Almeida, M.R. Laurent, V. Dubois, F. Claessens, C.A. O\u2019Brien, R. Bouillon, D. Vanderschueren, S.C. Manolagas, Estrogens and androgens in skeletal physiology and pathophysiology. Physiol. Rev. 97, 135\u2013187 (2017). https:\/\/doi.org\/10.1152\/physrev.00033.2015","journal-title":"Physiol. Rev."},{"key":"2715_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1677\/jme.0.0270249","volume":"27","author":"OK \u00d6z","year":"2001","unstructured":"O.K. \u00d6z, R. Millsaps, R. Welch, J. Birch, J.E. Zerwekh, Expression of aromatase in the human growth plate. J. Mol. Endocrinol. 27, 249\u2013253 (2001). https:\/\/doi.org\/10.1677\/jme.0.0270249","journal-title":"J. Mol. Endocrinol."},{"key":"2715_CR24","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0047-6374(01)00394-3","volume":"123","author":"R Takayanagi","year":"2002","unstructured":"R. Takayanagi, K. Goto, S. Suzuki, S. Tanaka, S. Shimoda, H. Nawata, Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyv. Mech. Ageing Dev. 123, 1107\u20131114 (2002). https:\/\/doi.org\/10.1016\/S0047-6374(01)00394-3","journal-title":"Mech. Ageing Dev."},{"key":"2715_CR25","first-page":"91","volume":"12","author":"MI New","year":"1989","unstructured":"M.I. New, J.M. Gertner, P.W. Speiser, P. Del Balzo, Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J. Endocrinol. Invest. 12, 91\u201395 (1989)","journal-title":"J. Endocrinol. Invest."},{"key":"2715_CR26","doi-asserted-by":"publisher","unstructured":"H.-G. D\u00f6rr, N. Schulze, M. Bettendorf, G. Binder, W. Bonfig, C. Denzer, D. Dunstheimer, K. Salzgeber, H. Schmidt, K.O. Schwab, E. Voss, M. Wabitsch, J. W\u00f6lfle, Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol. Cell. Pediatr. 7 (2020). https:\/\/doi.org\/10.1186\/s40348-020-00100-w","DOI":"10.1186\/s40348-020-00100-w"},{"key":"2715_CR27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3275\/7410","volume":"34","author":"S Einaudi","year":"2011","unstructured":"S. Einaudi, E. Napolitano, F. Restivo, G. Motta, M. Baldi, G. Tuli, E. Grosso, N. Migone, E. Menegatti, C. Manieri, Genotype, phenotype and hormonal levels correlation in non-classical congenital adrenal hyperplasia. J. Endocrinol. Invest. 34, 660\u2013664 (2011). https:\/\/doi.org\/10.3275\/7410","journal-title":"J. Endocrinol. Invest."},{"key":"2715_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.4158\/EP-2018-0617","volume":"25","author":"A Brener","year":"2019","unstructured":"A. Brener, A. Segev-Becker, N. Weintrob, R. Stein, H. Interator, A. Schachter-Davidov, G. Israeli, E. Elkon-Tamir, Y. Lebenthal, O. Eyal, A. Oren, Health-related quality of life in children and adolescents with nonclassic congenital adrenal hyperplasia. Endocr. Pract. 25, 794\u2013799 (2019). https:\/\/doi.org\/10.4158\/EP-2018-0617","journal-title":"Endocr. Pract."},{"key":"2715_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000337217","volume":"77","author":"KJ Pijnenburg-Kleizen","year":"2012","unstructured":"K.J. Pijnenburg-Kleizen, G.F. Borm, B.J. Otten, D.A. Schott, E.L. Van Den Akker, W.H. Stokvis-Brantsma, P.G. Voorhoeve, B. Bakker, H.L. Claahsen-Van Der Grinten, Absence of clinically relevant growth acceleration in untreated children with non-classical congenital adrenal hyperplasia. Horm. Res. Paediatr. 77, 164\u2013169 (2012). https:\/\/doi.org\/10.1159\/000337217","journal-title":"Horm. Res. Paediatr."},{"key":"2715_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/EJE-11-0119","volume":"165","author":"L Ghizzoni","year":"2011","unstructured":"L. Ghizzoni, M. Cappa, A. Vottero, G. Ubertini, D. Carta, N. Di Iorgi, V. Gasco, M. Marchesi, V. Raggi, A. Ibba, F. Napoli, A. Massimi, M. Maghnie, S. Loche, O. Porzio, Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche. Eur. J. Endocrinol. 165, 307\u2013314 (2011). https:\/\/doi.org\/10.1530\/EJE-11-0119","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000509079","volume":"93","author":"CS Clausen","year":"2020","unstructured":"C.S. Clausen, M.L. Ljubicic, K.M. Main, A.M. Andersson, J.H. Petersen, H. Frederiksen, M. Duno, T.H. Johannsen, A. Juul, Congenital adrenal hyperplasia in children: a pilot study of steroid hormones expressed as sex- and age-related standard deviation scores. Horm. Res. Paediatr. 93, 226\u2013238 (2020). https:\/\/doi.org\/10.1159\/000509079","journal-title":"Horm. Res. Paediatr."},{"key":"2715_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1530\/eje.0.1360188","volume":"136","author":"N Weintrob","year":"1997","unstructured":"N. Weintrob, Z. Dickerman, E. Sprecher, A. Galatzer, A. Pertzelan, Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height. Eur. J. Endocrinol. 136, 188\u2013195 (1997). https:\/\/doi.org\/10.1530\/eje.0.1360188","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/apa.12147","volume":"102","author":"O Eyal","year":"2013","unstructured":"O. Eyal, Y. Tenenbaum-Rakover, S. Shalitin, S. Israel, N. Weintrob, Adult height of subjects with nonclassical 21-hydroxylase deficiency. Acta Paediatr. Int. J. Paediatr. 102, 419\u2013423 (2013). https:\/\/doi.org\/10.1111\/apa.12147","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"key":"2715_CR34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1515\/jpem.2007.20.8.883","volume":"20","author":"L Trinh","year":"2007","unstructured":"L. Trinh, S. Nimkarn, M.I. New, K. Lin-Su, Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Pediatr. Endocrinol. Metab. 20, 883\u2013891 (2007). https:\/\/doi.org\/10.1515\/jpem.2007.20.8.883","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"2715_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1515\/jpem-2017-0088","volume":"30","author":"\u015e Sava\u015f-Erdeve","year":"2017","unstructured":"\u015e. Sava\u015f-Erdeve, S. \u00c7etinkaya, Z.Y. Abali, \u015e. Poyrazo\u01e7lu, F. Ba\u015f, M. Berbero\u01e7lu, Z. Slklar, \u00d6. Korkmaz, D. Bulu\u015f, E.D. Akba\u015f, T. G\u00fcran, E. B\u00f6ber, O. Akln, G.C. Yilmaz, Z. Aycan, Clinical, biochemical and genetic features with nonclassical 21-hydroxylase deficiency and final height. J. Pediatr. Endocrinol. Metab. 30, 759\u2013766 (2017). https:\/\/doi.org\/10.1515\/jpem-2017-0088","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"2715_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3275\/8194","volume":"36","author":"M Wasniewska","year":"2013","unstructured":"M. Wasniewska, A. Balsamo, M. Valenzise, A. Manganaro, G. Faggioli, S. Bombaci, V. Conti, M. Ferri, T. Aversa, A. Cicognani, F. De Luca,Increased large artery intima media thickness in adolescents with either classical or non-classical congenital adrenal hyperplasia. J. Endocrinol. Invest. 36, 12\u201315 (2013). https:\/\/doi.org\/10.3275\/8194","journal-title":"J. Endocrinol. Invest."},{"key":"2715_CR37","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1210\/jc.2012-2102","volume":"97","author":"GP Finkielstain","year":"2012","unstructured":"G.P. Finkielstain, M.S. Kim, N. Sinaii, M. Nishitani, C. Van Ryzin, S.C. Hill, J.C. Reynolds, R.M. Hanna, D.P. Merke, Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 97, 4429\u20134438 (2012). https:\/\/doi.org\/10.1210\/jc.2012-2102","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR38","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1530\/EJE-13-0128","volume":"168","author":"TS Han","year":"2013","unstructured":"T.S. Han, N. Krone, D.S. Willis, G.S. Conway, S. Hahner, D.A. Rees, R.H. Stimson, B.R. Walker, W. Arlt, R.J. Ross, Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur. J. Endocrinol. 168, 887\u2013893 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0128","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR39","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1210\/jc.2002-021433","volume":"88","author":"G Pinto","year":"2003","unstructured":"G. Pinto, V. Tardy, C. Trivin, C. Thalassinos, S. Lortat-Jacob, C. Nihoul-F\u00e9k\u00e9t\u00e9, Y. Morel, R. Brauner, Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. J. Clin. Endocrinol. Metab. 88, 2624\u20132633 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021433","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000053253","volume":"54","author":"C Paganini","year":"2000","unstructured":"C. Paganini, G. Radetti, C. Livieri, V. Braga, D. Migliavacca, S. Adami, Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm. Res. 54, 164\u2013168 (2000). https:\/\/doi.org\/10.1159\/000053253","journal-title":"Horm. Res."},{"key":"2715_CR41","doi-asserted-by":"publisher","unstructured":"A. Ventura, G. Brunetti, S. Colucci, A. Oranger, F. Ladisa, L. Cavallo, M. Grano, M.F. Faienza, Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency. Biomed. Res. Int. 2013 (2013). https:\/\/doi.org\/10.1155\/2013\/250462","DOI":"10.1155\/2013\/250462"},{"key":"2715_CR42","doi-asserted-by":"publisher","unstructured":"K. Lin-Su, M.I. New, Effects of adrenal steroids on the bone metabolism of children with congenital adrenal hyperplasia. Ann. N. Y. Acad. Sci. 345\u2013351 (2007). https:\/\/doi.org\/10.1196\/annals.1402.040","DOI":"10.1196\/annals.1402.040"},{"key":"2715_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2265.1995.tb01890.x","volume":"43","author":"HU Schweikert","year":"1995","unstructured":"H.U. Schweikert, L. Wolf, G. Romalo, Oestrogen formation from androstenedione in human bone. Clin. Endocrinol. 43, 37\u201342 (1995). https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb01890.x","journal-title":"Clin. Endocrinol."},{"key":"2715_CR44","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cen.12507","volume":"82","author":"D El-Maouche","year":"2015","unstructured":"D. El-Maouche, S. Collier, M. Prasad, J.C. Reynolds, D.P. Merke, Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. 82, 330\u2013337 (2015). https:\/\/doi.org\/10.1111\/cen.12507","journal-title":"Clin. Endocrinol."},{"key":"2715_CR45","doi-asserted-by":"publisher","unstructured":"G. Brunetti, M.F. Faienza, L. Piacente, A. Ventura, A. Oranger, C. Carbone, A. Di Benedetto, G. Colaianni, M. Gigante, G. Mori, L. Gesualdo, S. Colucci, L. Cavallo, M. Grano, High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. Am. J. Physiol. - Endocrinol. Metab. 304 (2013). https:\/\/doi.org\/10.1152\/ajpendo.00535.2012","DOI":"10.1152\/ajpendo.00535.2012"},{"key":"2715_CR46","doi-asserted-by":"publisher","unstructured":"K. Sarafoglou, O.Y. Addo, L. Turcotte, N. Otten, A. Wickremasinghe, S. Pittock, J. Kyllo, A.N. Lteif, J.H. Himes, B.S. Miller, Impact of hydrocortisone on adult height in congenital adrenal hyperplasia\u2014the Minnesota cohort. J. Pediatr. 164 (2014). https:\/\/doi.org\/10.1016\/j.jpeds.2014.01.011","DOI":"10.1016\/j.jpeds.2014.01.011"},{"key":"2715_CR47","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1210\/jc.2007-0744","volume":"92","author":"H Falhammar","year":"2007","unstructured":"H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskj\u00f6ld, K. Hagenfeldt, M. Thor\u00e9n, Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92, 4643\u20134649 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0744","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/8756-3282(96)00003-8","volume":"18","author":"S Mora","year":"1996","unstructured":"S. Mora, F. Saggion, G. Russo, G. Weber, A. Bellini, C. Prinster, G. Chiumello, Bone density in young patients with congenital adrenal hyperplasia. Bone 18, 337\u2013340 (1996). https:\/\/doi.org\/10.1016\/8756-3282(96)00003-8","journal-title":"Bone"},{"key":"2715_CR49","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s12020-014-0332-9","volume":"48","author":"M Delvecchio","year":"2015","unstructured":"M. Delvecchio, L. Soldano, A. Lonero, A. Ventura, P. Giordano, L. Cavallo, M. Grano, G. Brunetti, M.F. Faienza, Evaluation of impact of steroid replacement treatment on bone health in children with 21-hydroxylase deficiency. Endocrine 48, 995\u20131000 (2015). https:\/\/doi.org\/10.1007\/s12020-014-0332-9","journal-title":"Endocrine"},{"key":"2715_CR50","doi-asserted-by":"publisher","unstructured":"M.K. Auer, L. Paizoni, L.C. Hofbauer, M. Rauner, Y. Chen, H. Schmidt, A. Huebner, M. Bidlingmaier, N. Reisch, Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 204 (2020). https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105734","DOI":"10.1016\/j.jsbmb.2020.105734"},{"key":"2715_CR51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/cen.14149","volume":"92","author":"G Riehl","year":"2020","unstructured":"G. Riehl, N. Reisch, R. Roehle, H. Claahsen van der Grinten, H. Falhammar, M. Quinkler, Bone mineral density and fractures in congenital adrenal hyperplasia: findings from the dsd-LIFE study. Clin. Endocrinol. 92, 284\u2013294 (2020). https:\/\/doi.org\/10.1111\/cen.14149","journal-title":"Clin. Endocrinol."},{"key":"2715_CR52","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/EJE-07-0887","volume":"158","author":"Z Chakhtoura","year":"2008","unstructured":"Z. Chakhtoura, A. Bachelot, D. Samara-Boustani, J.C. Ruiz, B. Donadille, J. Dulon, S. Christin-Ma\u00eetre, C. Bouvattier, M.C. Raux-Demay, P. Bouchard, J.C. Carel, J. Leger, F. Kuttenn, M. Polak, P. Touraine, Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 158, 879\u2013887 (2008). https:\/\/doi.org\/10.1530\/EJE-07-0887","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000098017","volume":"67","author":"A Bachelot","year":"2007","unstructured":"A. Bachelot, G. Plu-Bureau, E. Thibaud, K. Laborde, G. Pinto, D. Samara, C. Nihoul-F\u00e9k\u00e9t\u00e9, F. Kuttenn, M. Polak, P. Touraine, Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm. Res. 67, 268\u2013276 (2007). https:\/\/doi.org\/10.1159\/000098017","journal-title":"Horm. Res."},{"key":"2715_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-15-1096","volume":"174","author":"J Schulz","year":"2016","unstructured":"J. Schulz, K.R. Frey, M.S. Cooper, K. Zopf, M. Ventz, S. DIederich, M. Quinkler, Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency. Eur. J. Endocrinol. 174, 531\u2013538 (2016). https:\/\/doi.org\/10.1530\/EJE-15-1096","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR55","doi-asserted-by":"publisher","unstructured":"A. Halper, M.C. Hooke, M.T. Gonzalez-Bolanos, N. Vanderburg, T.N. Tran, J. Torkelson, K. Sarafoglou, Health-related quality of life in children with congenital adrenal hyperplasia. Health Qual. Life Outcomes. 15 (2017). https:\/\/doi.org\/10.1186\/s12955-017-0769-7","DOI":"10.1186\/s12955-017-0769-7"},{"key":"2715_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/jim-2016-000085","volume":"65","author":"AM Agoston","year":"2017","unstructured":"A.M. Agoston, M.T. Gonzalez-Bolanos, M. Semrud-Clikeman, N. Vanderburg, K. Sarafoglou, Executive functioning in children with congenital adrenal hyperplasia. J. Investig. Med. 65, 49\u201352 (2017). https:\/\/doi.org\/10.1136\/jim-2016-000085","journal-title":"J. Investig. Med."},{"key":"2715_CR57","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1210\/jc.2006-0062","volume":"91","author":"C Moran","year":"2006","unstructured":"C. Moran, R. Azziz, N. Weintrob, S.F. Witchel, V. Rohmer, D. Dewailly, J.A.M. Marcondes, M. Pugeat, P.W. Speiser, D. Pignatelli, B.B. Mendonca, T.A.S. Bachega, H.F. Escobar-Morreale, E. Carmina, F. Fruzzetti, F. Kelestimur, Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J. Clin. Endocrinol. Metab. 91, 3451\u20133456 (2006). https:\/\/doi.org\/10.1210\/jc.2006-0062","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR58","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1055\/s-0034-1389901","volume":"47","author":"S Ben-Shachar","year":"2014","unstructured":"S. Ben-Shachar, I. Ayalon, H. Reznik-Wolf, Y. Tenenbaum-Rakover, N. Zuckerman-Levin, O. Cohen, A. Lifshitz, M. Fraenkel, Y. Toledano, V. Roash, I. Koren, D. Modan-Moses, D. Hirsch, A. Schachter-Davidov, S. Israel, O. Eyal, N. Weintrob, Androgen receptor cag repeat length in relation to phenotype among females with nonclassical 21-hydroxylase deficiency. Horm. Metab. Res. 47, 491\u2013496 (2014). https:\/\/doi.org\/10.1055\/s-0034-1389901","journal-title":"Horm. Metab. Res."},{"key":"2715_CR59","first-page":"458","volume":"30","author":"N Akhtar","year":"2018","unstructured":"N. Akhtar, Z. Hayat, A. Bari, Female pseudo hermaphroditism: late onset congenital adrenal hyperplasia. J. Ayub Med. Coll. Abbottabad. 30, 458\u2013462 (2018)","journal-title":"J. Ayub Med. Coll. Abbottabad."},{"key":"2715_CR60","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1365-2265.2000.00995.x","volume":"52","author":"TASS Bachega","year":"2000","unstructured":"T.A.S.S. Bachega, A.E.C. Billerbeck, J.A.M. Marcondes, G. Madureira, I.J.P. Arnhold, B.B. Mendonca, Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. 52, 601\u2013607 (2000). https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00995.x","journal-title":"Clin. Endocrinol."},{"key":"2715_CR61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/nyas.13370","volume":"1402","author":"S Gurgov","year":"2017","unstructured":"S. Gurgov, K.J. Bernab\u00e9, J. Stites, C.M. Cunniff, K. Lin-Su, D. Felsen, M.I. New, D.P. Poppas, Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype. Ann. N. Y. Acad. Sci. 1402, 56\u201363 (2017). https:\/\/doi.org\/10.1111\/nyas.13370","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2715_CR62","doi-asserted-by":"publisher","unstructured":"V.O. Moura-Massari, F.S. Cunha, L.G. Gomes, D.B.D. Gomes, J.A.M. Marcondes, G. Madureira, B.B. De Mendonca, T.A.S.S. Bachega, The presence of clitoromegaly in the nonclassical form of 21-hydroxylase deficiency could be partially modulated by the CAG polymorphic tract of the androgen receptor gene. PLoS ONE. 11 (2016). https:\/\/doi.org\/10.1371\/journal.pone.0148548","DOI":"10.1371\/journal.pone.0148548"},{"key":"2715_CR63","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"N.F. Goodman, R.H. Cobin, W. Futterweit, J.S. Glueck, R.S. Legro, E. Carmina, American association of clinical endocrinologists, American college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 2. Endocr. Pract. 21, 1415\u20131426 (2015). https:\/\/doi.org\/10.4158\/EP15748.DSCPT2","journal-title":"Endocr. Pract."},{"key":"2715_CR64","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1210\/jcem-70-3-642","volume":"70","author":"P Spritzer","year":"1990","unstructured":"P. Spritzer, L. Billaud, J.C. Thalabard, P. Birman, I. Mowszowicz, M.C. Raux-Demay, F. Clair, F. Kuttenn, P. Mauvais-Jarvis, Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J. Clin. Endocrinol. Metab. 70, 642\u2013646 (1990). https:\/\/doi.org\/10.1210\/jcem-70-3-642","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR65","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1210\/jc.2009-1383","volume":"95","author":"M Bidet","year":"2010","unstructured":"M. Bidet, C. Bellann\u00e9-Chantelot, M.B. Galand-Portier, J.L. Golmard, V. Tardy, Y. Morel, S. Clauin, C. Coussieu, P. Boudou, I. Mowzowicz, A. Bachelot, P. Touraine, F. Kuttenn, Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 95, 1182\u20131190 (2010). https:\/\/doi.org\/10.1210\/jc.2009-1383","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR66","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1210\/jcem.74.3.1310999","volume":"74","author":"S Feldman","year":"1992","unstructured":"S. Feldman, L. Billaud, J.C. Thalabard, M.C. Raux-Demay, I. Mowszowicz, F. Kuttenn, P. Mauvais-Jarvis, Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 74, 635\u2013639 (1992). https:\/\/doi.org\/10.1210\/jcem.74.3.1310999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR67","doi-asserted-by":"publisher","unstructured":"M. Tetsuka, S.G. Hillier, Differential regulation of aromatase and androgen receptor in granulosa cells. J. Steroid Biochem. Mol. Biol., 1997, 233\u2013239. https:\/\/doi.org\/10.1016\/S0960-0760(96)00207-5","DOI":"10.1016\/S0960-0760(96)00207-5"},{"key":"2715_CR68","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1210\/en.2019-00101","volume":"160","author":"O Astapova","year":"2019","unstructured":"O. Astapova, B.M.N. Minor, S.R. Hammes, Physiological and pathological androgen actions in the ovary. Endocrinology 160, 1166\u20131174 (2019). https:\/\/doi.org\/10.1210\/en.2019-00101","journal-title":"Endocrinology"},{"key":"2715_CR69","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/jog.13288","volume":"43","author":"Y Kawarai","year":"2017","unstructured":"Y. Kawarai, H. Ishikawa, T. Segawa, S. Teramoto, T. Tanaka, M. Shozu, High serum progesterone associated with infertility in a woman with nonclassic congenital adrenal hyperplasia. J. Obstet. Gynaecol. Res. 43, 946\u2013950 (2017). https:\/\/doi.org\/10.1111\/jog.13288","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"2715_CR70","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1093\/humrep\/del284","volume":"21","author":"AN Andersen","year":"2006","unstructured":"A.N. Andersen, P. Devroey, J.C. Arce, Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum. Reprod. 21, 3217\u20133227 (2006). https:\/\/doi.org\/10.1093\/humrep\/del284","journal-title":"Hum. Reprod."},{"key":"2715_CR71","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/humrep\/der126","volume":"26","author":"E Labarta","year":"2011","unstructured":"E. Labarta, J.A. Mart\u00cdnez-Conejero, P. Alam\u00e1, J.A. Horcajadas, A. Pellicer, C. Sim\u00f3n, E. Bosch, Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum. Reprod. 26, 1813\u20131825 (2011). https:\/\/doi.org\/10.1093\/humrep\/der126","journal-title":"Hum. Reprod."},{"key":"2715_CR72","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","volume":"70","author":"GS Conway","year":"2009","unstructured":"G.S. Conway, A. Caster\u00e0s, P. De Silva, G. Rumsby, Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin. Endocrinol. 70, 833\u2013837 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03563.x","journal-title":"Clin. Endocrinol."},{"key":"2715_CR73","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1530\/EJE-11-0019","volume":"164","author":"R Nandagopal","year":"2011","unstructured":"R. Nandagopal, N. Sinaii, N.A. Avila, C. Van Ryzin, W. Chen, G.P. Finkielstain, S.P. Mehta, N.B. McDonnell, D.P. Merke, Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. Eur. J. Endocrinol. 164, 977\u2013984 (2011). https:\/\/doi.org\/10.1530\/EJE-11-0019","journal-title":"Eur. J. Endocrinol."},{"key":"2715_CR74","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1530\/EC-17-0094","volume":"6","author":"A Bachelot","year":"2017","unstructured":"A. Bachelot, M. Vialon, A. Baptiste, I. Tejedor, C. Elie, M. Polak, P. Touraine, C. Bricaire, M. Castanet, J. Young, S. Christin-Maitre, A.C. Bouthillier-Voisin, C. Courtillot, J. Allouche, L.R. Quillacq, T. Brue, T. Richard, I. Raingeard, T. Godeau, P. Caron, M. Pugeat, F. Galland, F. Torremocha, E. Requeda, M.C.R. Demay, Y. Boutonnat, J. Samrani, L. Bernard, M.C.R. Demay, A. David, D. Samara- Boustani, C. Boissinot, E. Mallet, C. Pauwels, P. Czernichow, A. Leblanc, I. Netchine, H. Crosnier, R. Rappaport, B. Esteva, J.C. Carel, G. Pinto, J. Leger, S. Baron, Gourmelen, Impact of transition on quality of life in patients with congenital adrenal hyperplasia diagnosed during childhood. Endocr. Connect. 6, 422\u2013429 (2017). https:\/\/doi.org\/10.1530\/EC-17-0094","journal-title":"Endocr. Connect."},{"key":"2715_CR75","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1210\/jc.2009-2639","volume":"95","author":"A Nordenstr\u00f6m","year":"2010","unstructured":"A. Nordenstr\u00f6m, L. Fris\u00e9n, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thor\u00e9n, K. Hagenfeldt, A. Nordenskj\u00f6ld, Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients\u2019 perception. J. Clin. Endocrinol. Metab. 95, 3633\u20133640 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2639","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR76","doi-asserted-by":"publisher","unstructured":"T. Hirvikoski, T. Lindholm, S. Lajic, A. Nordenstr\u00f6m, Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia\u2014a pilot study. Acta Paediatr. 100 (2011). https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02260.x","DOI":"10.1111\/j.1651-2227.2011.02260.x"},{"key":"2715_CR77","doi-asserted-by":"publisher","unstructured":"A. Van\u2019t Westeinde, L. Karlsson, A. Nordenstr\u00f6m, N. Padilla, S. Lajic, First-trimester prenatal dexamethasone treatment is associated with alterations in brain structure at adult age. J. Clin. Endocrinol. Metab. 105 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa340","DOI":"10.1210\/clinem\/dgaa340"},{"key":"2715_CR78","doi-asserted-by":"publisher","unstructured":"A. van\u2019t Westeinde, M. Zimmermann, V. Messina, L. Karlsson, N. Padilla, S. Lajic, First trimester DEX treatment is not associated with altered brain activity during working memory performance in adults. J. Clin. Endocrinol. Metab. 105 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa611.","DOI":"10.1210\/clinem\/dgaa611"},{"key":"2715_CR79","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/humrep\/den118","volume":"23","author":"K Hagenfeldt","year":"2008","unstructured":"K. Hagenfeldt, P.O. Janson, G. Holmdahl, H. Falhammar, H. Filipsson, L. Fris\u00e9n, M. Thor\u00e9n, A. Nordenskj\u00f6ld, Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Reprod. 23, 1607\u20131613 (2008). https:\/\/doi.org\/10.1093\/humrep\/den118","journal-title":"Hum. Reprod."},{"key":"2715_CR80","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1055\/s-0035-1565183","volume":"48","author":"H Remde","year":"2016","unstructured":"H. Remde, K. Zopf, J. Schwander, M. Quinkler, Fertility and pregnancy in primary adrenal insufficiency in Germany. Horm. Metab. Res. 48, 306\u2013311 (2016). https:\/\/doi.org\/10.1055\/s-0035-1565183","journal-title":"Horm. Metab. Res."},{"key":"2715_CR81","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2265.2010.03920.x","volume":"74","author":"N Reisch","year":"2011","unstructured":"N. Reisch, S. Hahner, B. Bleicken, L. Flade, F.P. Gil, M. Loeffler, M. Ventz, A. Hinz, F. Beuschlein, B. Allolio, M. Reincke, M. Quinkler, Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin. Endocrinol. 74, 166\u2013173 (2011). https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03920.x","journal-title":"Clin. Endocrinol."},{"key":"2715_CR82","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/cen.13429","volume":"87","author":"O Eyal","year":"2017","unstructured":"O. Eyal, I. Ayalon-Dangur, A. Segev-Becker, A. Schachter-Davidov, S. Israel, N. Weintrob, Pregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome. Clin. Endocrinol. 87, 552\u2013556 (2017). https:\/\/doi.org\/10.1111\/cen.13429","journal-title":"Clin. Endocrinol."},{"key":"2715_CR83","doi-asserted-by":"publisher","unstructured":"M.A. Sanchez-Garrido, M. Tena-Sempere, Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol. Metab. 35 (2020). https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","DOI":"10.1016\/j.molmet.2020.01.001"},{"key":"2715_CR84","doi-asserted-by":"publisher","unstructured":"D. Macut, V. Zdravkovi\u0107, J. Bjeki\u0107-Macut, G. Mastorakos, D. Pignatelli, Metabolic perspectives for non-classical congenital adrenal hyperplasia with relation to the classical form of the disease. Front. Endocrinol. 10 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00681","DOI":"10.3389\/fendo.2019.00681"},{"key":"2715_CR85","doi-asserted-by":"publisher","unstructured":"S. Livadas, C. Bothou, Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach. Front. Endocrinol. 10 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00366","DOI":"10.3389\/fendo.2019.00366"},{"key":"2715_CR86","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, L. Fris\u00e9n, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskj\u00f6ld, A. Nordenstr\u00f6m, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a swedish population-based national cohort study. J. Clin. Endocrinol. Metab. 100, 3520\u20133528 (2015). https:\/\/doi.org\/10.1210\/JC.2015-2093","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR87","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","volume":"99","author":"H Falhammar","year":"2014","unstructured":"H. Falhammar, L. Fris\u00e9n, C. Norrby, A.L. Hirschberg, C. Almqvist, A. Nordenskj\u00f6ld, A. Nordenstr\u00f6m, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99, E2715\u2013E2721 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2957","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR88","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4103\/2230-8210.102995","volume":"16","author":"M Kamoun","year":"2012","unstructured":"M. Kamoun, F. Mnif, N. Charfi, B. Naceur, N. Kallel, N. Rekik, Z. Mnif, M. Sfar, M. Sfar, M. Hachicha, M. Abid, M. Mnif, Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Indian J. Endocrinol. Metab. 16, 939 (2012). https:\/\/doi.org\/10.4103\/2230-8210.102995","journal-title":"Indian J. Endocrinol. Metab."},{"key":"2715_CR89","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"W. Arlt, D.S. Willis, S.H. Wild, N. Krone, E.J. Doherty, S. Hahner, T.S. Han, P.V. Carroll, G.S. Conway, D.A. Rees, R.H. Stimson, B.R. Walker, J.M.C. Connell, R.J. Ross, W. Arlt, U. Ayyagari, S. Ball, J.S. Bevan, S.A. Booth, U. Bradley, S.L. Breen, P.V. Carroll, M. Clements, T. Chambers, T.R. Cole, J.M.C. Connell, G. Conway, M. Daly, J.R. Davis, S.A. Doane, E.J. Doherty, T.S. Han, I.A. Hughes, S. Hunter, S.V. Ibbotson, N. Krone, S.J. MacDonald, K. Mullen, S. Peacey, C. Perry, D.W. Ray, D.A. Rees, R.J.M. Ross, M. Scanlon, H. Simpson, P.M. Stewart, S.S.E. Stewart, R.H. Stimson, J.P. Vora, D. Wake, S.E. Walker, B.R. Walker, J.A.H. Wass, S.P. Whittingham, D.S. Willis, S.D. Wright, F.C. Wu, Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab. 95, 5110\u20135121 (2010). https:\/\/doi.org\/10.1210\/jc.2010-0917","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR90","doi-asserted-by":"publisher","unstructured":"L. de Vries, Y. Lebenthal, M. Phillip, S. Shalitin, A. Tenenbaum, R. Bello, Obesity and cardiometabolic risk factors in children and young adults with non-classical 21-hydroxylase deficiency. Front. Endocrinol. 10 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00698","DOI":"10.3389\/fendo.2019.00698"},{"key":"2715_CR91","doi-asserted-by":"publisher","unstructured":"R.M. Williams, A. Deeb, K.K. Ong, W. Bich, P.R. Murgatroyd, I.A. Hughes, C.L. Acerini, Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia. Clin. Endocrinol. 72 (2010) 155\u2013160. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03587.x","DOI":"10.1111\/j.1365-2265.2009.03587.x"},{"key":"2715_CR92","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1507\/endocrj.51.601","volume":"51","author":"F Bayraktar","year":"2004","unstructured":"F. Bayraktar, D. Dereli, A.G. \u00d6zgen, C. Yilmaz, Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia. Endocr. J. 51, 601\u2013608 (2004). https:\/\/doi.org\/10.1507\/endocrj.51.601","journal-title":"Endocr. J."},{"key":"2715_CR93","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/00015385.2019.1666964","volume":"75","author":"R Krysiak","year":"2020","unstructured":"R. Krysiak, K. Kowalcze, B. Marek, B. Okopie\u0144, Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia. Acta Cardiol. 75, 705\u2013710 (2020). https:\/\/doi.org\/10.1080\/00015385.2019.1666964","journal-title":"Acta Cardiol."},{"key":"2715_CR94","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.pharep.2019.01.014","volume":"71","author":"R Krysiak","year":"2019","unstructured":"R. Krysiak, K. Kowalcze, A. Bednarska-Czerwi\u0144ska, B. Okopie\u0144, The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: a pilot study. Pharmacol. Rep. 71, 417\u2013421 (2019). https:\/\/doi.org\/10.1016\/j.pharep.2019.01.014","journal-title":"Pharmacol. Rep."},{"key":"2715_CR95","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0035-1569375","volume":"124","author":"R Krysiak","year":"2016","unstructured":"R. Krysiak, K. Kowalcze, A. Bednarska-Czerwi\u0144ska, B. Okopie\u0144, The effect of simvastatin on plasma steroid hormone levels in metformin-treated women with non-classic congenital adrenal hyperplasia. Exp. Clin. Endocrinol. Diabetes 124, 215\u2013219 (2016). https:\/\/doi.org\/10.1055\/s-0035-1569375","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2715_CR96","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1210\/jcem.75.6.1464643","volume":"75","author":"PW Speiser","year":"1992","unstructured":"P.W. Speiser, J. Serrat, M.I. New, J.M. Gertner, Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 75, 1421\u20131424 (1992). https:\/\/doi.org\/10.1210\/jcem.75.6.1464643","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR97","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000086363","volume":"63","author":"F Saygili","year":"2005","unstructured":"F. Saygili, A. Oge, C. Yilmaz, Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm. Res. 63, 270\u2013274 (2005). https:\/\/doi.org\/10.1159\/000086363","journal-title":"Horm. Res."},{"key":"2715_CR98","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1055\/s-0034-1382048","volume":"122","author":"R Krysiak","year":"2014","unstructured":"R. Krysiak, B. Okopien, The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia. Exp. Clin. Endocrinol. Diabetes 122, 568\u2013571 (2014). https:\/\/doi.org\/10.1055\/s-0034-1382048","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2715_CR99","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1210\/jcem.74.3.1311000","volume":"74","author":"S Jaresch","year":"1992","unstructured":"S. Jaresch, E. Kornely, H.K. Kley, R. Schlaghecke, Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 74, 685\u2013689 (1992). https:\/\/doi.org\/10.1210\/jcem.74.3.1311000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR100","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1055\/s-0035-1549911","volume":"47","author":"B Kiedrowicz","year":"2015","unstructured":"B. Kiedrowicz, A. Binczak-Kuleta, J. Lubikowski, M. Koziolek, E. Andrysiak-Mamos, M. Ostanek-Panka, A. Ciechanowicz, A. Syrenicz, Prevalence and clinical outcome of CYP21A2 gene mutations in patients with nonfunctional adrenal incidentalomas. Horm. Metab. Res. 47, 662\u2013667 (2015). https:\/\/doi.org\/10.1055\/s-0035-1549911","journal-title":"Horm. Metab. Res."},{"key":"2715_CR101","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4158\/EP151085.RA","volume":"22","author":"H Falhammar","year":"2016","unstructured":"H. Falhammar, D.J. Torpy, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as adrenal incidentaloma: a systematic review and meta-analysis. Endocr. Pract. 22, 736\u2013752 (2016). https:\/\/doi.org\/10.4158\/EP151085.RA","journal-title":"Endocr. Pract."},{"key":"2715_CR102","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1515\/JPEM.2001.14.4.415","volume":"14","author":"LR Giacaglia","year":"2001","unstructured":"L.R. Giacaglia, B.B. Mendonca, G. Madureira, K.F.F. Melo, C.A. Suslik, I.J.P. Arnhold, T.A.S.S. Bachega, Adrenal nodules in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: regression after adequate hormonal control. J. Pediatr. Endocrinol. Metab. 14, 415\u2013419 (2001). https:\/\/doi.org\/10.1515\/JPEM.2001.14.4.415","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"2715_CR103","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1210\/jc.2014-1342","volume":"99","author":"R Lib\u00e9","year":"2014","unstructured":"R. Lib\u00e9, W. Arlt, E. Louiset, C. Waintrop, J. Guibourdenche, M. Sibony, E. Clauser, L. Groussin, A feminizing adrenocortical carcinoma in the context of a late onset 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99, 1943\u20131944 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1342","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR104","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000369901","volume":"83","author":"A Stoupa","year":"2015","unstructured":"A. Stoupa, L. Gonz\u00e1lez-Brice\u00f1o, G. Pinto, D. Samara-Boustani, C. Thalassinos, I. Flechtner, J. Beltrand, M. Bidet, A. Simon, M. Piketty, K. Laborde, Y. Morel, C. Bellann\u00e9-Chantelot, P. Touraine, M. Polak, Inadequate cortisol response to the tetracosactide (Synacthen\u00ae) test in non-classic congenital adrenal hyperplasia: an exception to the rule? Horm. Res. Paediatr. 83, 262\u2013267 (2015). https:\/\/doi.org\/10.1159\/000369901","journal-title":"Horm. Res. Paediatr."},{"key":"2715_CR105","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1515\/jpem-2016-0216","volume":"29","author":"FH Karachaliou","year":"2016","unstructured":"F.H. Karachaliou, M. Kafetzi, M. Dracopoulou, E. Vlachopapadopoulou, S. Leka, A. Fotinou, S. Michalacos, Cortisol response to adrenocorticotropin testing in non-classical congenital adrenal hyperplasia (NCCAH). J. Pediatr. Endocrinol. Metab. 29, 1365\u20131371 (2016). https:\/\/doi.org\/10.1515\/jpem-2016-0216","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"2715_CR106","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1210\/jc.2018-00208","volume":"103","author":"D El-Maouche","year":"2018","unstructured":"D. El-Maouche, C.J. Hargreaves, N. Sinaii, A. Mallappa, P. Veeraraghavan, D.P. Merke, Longitudinal assessment of illnesses, stress dosing, and illness sequelae in patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 103, 2336\u20132345 (2018). https:\/\/doi.org\/10.1210\/jc.2018-00208","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR107","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4158\/EP-2019-0509","volume":"26","author":"A Segev-Becker","year":"2020","unstructured":"A. Segev-Becker, R. Jacobson, R. Stein, O. Eyal, A. Oren, A. Schachter-Davidov, G. Israeli, Y. Lebenthal, N. Weintrob, Women with nonclassic congenital adrenal hyperplasia have gender, sexuality, and quality-of-life features similar to those of nonaffected women. Endocr. Pract. 26, 535\u2013542 (2020). https:\/\/doi.org\/10.4158\/EP-2019-0509","journal-title":"Endocr. Pract."},{"key":"2715_CR108","doi-asserted-by":"publisher","unstructured":"M. Rapp, E. Mueller-Godeffroy, P. Lee, R. Roehle, B.P.C. Kreukels, B. K\u00f6hler, A. Nordenstr\u00f6m, C. Bouvattier, U. Thyen, Multicentre cross-sectional clinical evaluation study about quality of life in adults with disorders\/differences of sex development (DSD) compared to country specific reference populations (dsd-LIFE). Health Qual. Life Outcomes. 16 (2018). https:\/\/doi.org\/10.1186\/s12955-018-0881-3","DOI":"10.1186\/s12955-018-0881-3"},{"key":"2715_CR109","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11136-019-02350-2","volume":"29","author":"L Carroll","year":"2020","unstructured":"L. Carroll, C. Graff, M. Wicks, A. Diaz Thomas, Living with an invisible illness: a qualitative study exploring the lived experiences of female children with congenital adrenal hyperplasia. Qual. Life Res. 29, 673\u2013681 (2020). https:\/\/doi.org\/10.1007\/s11136-019-02350-2","journal-title":"Qual. Life Res."},{"key":"2715_CR110","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10508-006-9068-9","volume":"35","author":"HFL Meyer-Bahlburg","year":"2006","unstructured":"H.F.L. Meyer-Bahlburg, C. Dolezal, S.W. Baker, A.A. Ehrhardt, M.I. New, Gender development in women with congenital adrenal hyperplasia as a function of disorder severity. Arch. Sex. Behav. 35, 667\u2013684 (2006). https:\/\/doi.org\/10.1007\/s10508-006-9068-9","journal-title":"Arch. Sex. Behav."},{"key":"2715_CR111","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s10508-016-0693-7","volume":"45","author":"JJ Endendijk","year":"2016","unstructured":"J.J. Endendijk, A.M. Beltz, S.M. McHale, K. Bryk, S.A. Berenbaum, Linking prenatal androgens to gender-related attitudes, identity, and activities: evidence from girls with congenital adrenal hyperplasia. Arch. Sex. Behav. 45, 1807\u20131815 (2016). https:\/\/doi.org\/10.1007\/s10508-016-0693-7","journal-title":"Arch. Sex. Behav."},{"key":"2715_CR112","doi-asserted-by":"publisher","unstructured":"H.F.L. Meyer-Bahlburg, C. Dolezal, S.W. Baker, M.I. New, Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch. Sex. Behav. 2008, 85\u201399. https:\/\/doi.org\/10.1007\/s10508-007-9265-1","DOI":"10.1007\/s10508-007-9265-1"},{"key":"2715_CR113","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jsxm.2015.11.002","volume":"13","author":"R Krysiak","year":"2016","unstructured":"R. Krysiak, A. Drosdzol-Cop, V. Skrzypulec-Plinta, B. Okopien, Sexual function and depressive symptoms in young women with nonclassic congenital adrenal hyperplasia. J. Sex. Med. 13, 34\u201339 (2016). https:\/\/doi.org\/10.1016\/j.jsxm.2015.11.002","journal-title":"J. Sex. Med."},{"key":"2715_CR114","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1210\/jc.2007-0556","volume":"93","author":"A Nordenskj\u00f6ld","year":"2008","unstructured":"A. Nordenskj\u00f6ld, G. Holmdahl, L. Fris\u00e9n, H. Falhammar, H. Filipsson, M. Thor\u00e9n, P.O. Janson, K. Hagenfeldt, Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 93, 380\u2013386 (2008). https:\/\/doi.org\/10.1210\/jc.2007-0556","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2715_CR115","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.jsxm.2019.07.009","volume":"16","author":"MH Schernthaner-Reiter","year":"2019","unstructured":"M.H. Schernthaner-Reiter, S. Baumgartner-Parzer, H.C. Egarter, M. Krebs, A. Kautzky-Willer, K. Kirchheiner, A. Luger, M. Bayerle-Eder, Influence of genotype and hyperandrogenism on sexual function in women with congenital adrenal hyperplasia. J. Sex. Med. 16, 1529\u20131540 (2019). https:\/\/doi.org\/10.1016\/j.jsxm.2019.07.009","journal-title":"J. Sex. Med."},{"key":"2715_CR116","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.psyneuen.2015.06.017","volume":"60","author":"H Engberg","year":"2015","unstructured":"H. Engberg, A. Butwicka, A. Nordenstr\u00f6m, A.L. Hirschberg, H. Falhammar, P. Lichtenstein, A. Nordenskj\u00f6ld, L. Fris\u00e9n, M. Land\u00e9n, Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: a total population study. Psychoneuroendocrinology 60, 195\u2013205 (2015). https:\/\/doi.org\/10.1016\/j.psyneuen.2015.06.017","journal-title":"Psychoneuroendocrinology"},{"key":"2715_CR117","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1210\/js.2019-00122","volume":"3","author":"H Falhammar","year":"2019","unstructured":"H. Falhammar, L. Fris\u00e9n, A.L. Hirschberg, A. Nordenskj\u00f6ld, C. Almqvist, A. Nordenstr\u00f6m, Increased risk of autoimmune disorders in 21-hydroxylase deficiency: a Swedish population-based national cohort study. J. Endocr. Soc. 3, 1039\u20131052 (2019). https:\/\/doi.org\/10.1210\/js.2019-00122","journal-title":"J. Endocr. Soc."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02715-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02715-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:26:40Z","timestamp":1623950800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02715-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2715"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02715-z","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"20 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}